ANIX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Anixa Biosciences Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 3.42 USD
-7.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 15.9% above the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned -7.6%, after a 4.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 45/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: earnings are due in 38d.

Setup score 42 out of 100
Latest Close 3.42 USD 31 Jul 2026
1W Return -7.6% latest completed week
4W Return 4.6% short-term follow-through
12W Return 14.0% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 41.30% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.6% Latest completed week; four-week move 4.6%. Indicator stack 27/83 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.30% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 45/100 conviction; expected move 89.2%. News sentiment 57/100 52 relevant articles in the latest sentiment read. Event risk 38d Next report is scheduled for 09 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 15.9% above the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned -7.6%, after a 4.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3912-week average 0.18

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.39Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.6% over four weeks, 14.0% over 12 weeks, and 13.6% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W-7.6%
4W4.6%
12W14.0%
26W12.5%
52W13.6%
Active trend streak1 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.41Latest activity-pressure read.
Pressure change90.2%Four-week change in activity pressure.
Leadership-3.79Latest relative-leadership reading.
RS change69.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 67% Model confidence 67%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength73/100Blend of value, momentum, and quality. Underlying universe rank 28; rank 1 is best.
Value61/100Relative valuation strength. Underlying universe rank 40; rank 1 is best.
Quality60/100Profitability and accounting quality. Underlying universe rank 41; rank 1 is best.
Momentum61/100Medium-term price momentum. Underlying universe rank 40; rank 1 is best.
Growth61/100Revenue and earnings growth. Underlying universe rank 40; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-5.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-58.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.9%
Net share repurchases relative to market value.
Shareholder yield
-1.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

ANIX shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.26, expected move of 89.2%, and Sharemaestro trend signal active.

Conviction45/100
Expected move89.2%
Put/call volume0.26
Pressure69
Speculation2
Volatility96
Trend agreement23
Open options detail
Insider activity6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 52 relevant articles.

19 positive · 29 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings38dNext report is scheduled for 09 Sep 2026; event risk rises as the date approaches.
Options expected move89.2%Nearest-chain priced movement where available.
52-week drawdown-37.3%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2615 weeks finished lower.
Best week+17.8%Week of 19 Jun.
Worst week-8.1%Week of 5 Jun.
Latest week-7.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains3
Flat weeks1
Modest losses6
Sharp losses9
Recent vol9.0%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape38/100

Trend, activity pressure, participation, and risk combine to a 38/100 tape read.

 Indicator analysis38/100

Latest 12-week confirmation: trend 1/12, activity pressure 11/12, relative leadership 1/12.

Activity pressure 0.39; No reversal markers Next-Week ExpectancyNegative 41.30%

Next-week expectancy is negative with a 41.30% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors63/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 79; Small Cap Core rank 47 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options51/100

ANIX shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.26, expected move of 89.2%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 89.2% Sentiment57/100

Weighted news tone is neutral across 52 relevant articles.

Anixa Biosciences Inc (ANIX) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings38d

Next report is scheduled for 09 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20263.42 USD-7.6%2.95 USD3.19 USD1.41-3.791.2MOn
24 Jul 20263.70 USD8.8%2.94 USD3.20 USD1.434.471.9MOff
17 Jul 20263.40 USD11.1%2.93 USD3.20 USD1.25-5.641.3MOff
10 Jul 20263.06 USD-6.4%2.92 USD3.20 USD1.07-18.99942.2KOff
3 Jul 20263.27 USD17.2%2.94 USD3.20 USD0.74-12.331.7MOff
26 Jun 20262.79 USD-4.1%2.99 USD3.20 USD0.35-24.901.9MOff
19 Jun 20262.91 USD17.8%3.05 USD3.20 USD0.13-25.721.3MOff
12 Jun 20262.47 USD-0.4%3.10 USD3.20 USD-0.03-35.85613.4KOff
5 Jun 20262.48 USD-8.1%3.15 USD3.21 USD0.10-34.80680.1KOff
29 May 20262.70 USD-3.2%3.21 USD3.22 USD0.25-32.62394.1KOff
22 May 20262.79 USD-1.1%3.26 USD3.22 USD0.38-28.69455.8KOff
15 May 20262.82 USD-6.0%3.30 USD3.22 USD0.41-27.31545.5KOff
8 May 20263.00 USD-4.5%3.35 USD3.23 USD0.27-23.23549.3KOff
1 May 20263.14 USD3.0%3.39 USD3.23 USD-0.05-15.57666.0KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.